Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based Survey
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Background Observational studies showed that the profile of infective endocarditis (IE) significantly changed over the past decades. However, most studies involved referral centers. We conducted a population-based study to control for this referral bias. The objective was to update the description of characteristics of IE in France and to compare the profile of community-acquired versus healthcare-associated IE. Methods A prospective population-based observational study conducted in all medical facilities from 7 French regions (32% of French individuals aged ≥18 years) identified 497 adults with Duke-Li-definite IE who were first admitted to the hospital in 2008. Main measures included age-standardized and sex-standardized incidence of IE and multivariate Cox regression analysis for risk factors of in-hospital death. Results The age-standardized and sex-standardized annual incidence of IE was 33.8 (95% confidence interval [CI], 30.8-36.9) cases per million inhabitants. The incidence was highest in men aged 75-79 years. A majority of patients had no previously known heart disease. Staphylococci were the most common causal agents, accounting for 36.2% of cases (Staphylococcus aureus, 26.6%; coagulase-negative staphylococci, 9.7%). Healthcare-associated IE represented 26.7% of all cases and exhibited a clinical pattern significantly different from that of community-acquired IE. S. aureus as the causal agent of IE was the most important factor associated with in-hospital death in…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other studies [6][7][8] suggest that the risk of neurological deterioration during cardiac surgery after a stroke is lower than previously assumed, particularly in patients with silent cerebrovascular emboli.”
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742 · cited 1×
“residence, dates of first symptoms and first hospitalization, transfer from/to another facility, history of heart disease, comorbidities (including diabetes mellitus, cancer, dialysis, and immunosuppressive therapy), Charlson comorbidity index [13], procedures and other risk factors for IE, signs and symptoms of IE, e…”
BackgroundBurden of valvular heart diseases: a population-based study
Nkomo, V. T., Gardin, J. M., Skelton, T. N., Gottdiener, J. S., Scott, C. G., & Enriquez-Sarano, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69208-8 · Cited by 4,881 · cited 1×
“First, the decrease in rheumatic heart disease and the increase in degenerative heart diseases have led to an increase in patients’ age and frequency of comorbidities [2, 3].”
BackgroundProposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
Li, J. S., Sexton, D. J., Mick, N., Nettles, R., Fowler, V. G., Ryan, T., Bashore, T., & Corey, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313753 · Cited by 4,027 · cited 1×
“This process also included the validation of the diagnosis according to the Duke criteria modified by Li [20].”
MethodIung, B. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00201-x · Cited by 3,530 · cited 2×
“First, the decrease in rheumatic heart disease and the increase in degenerative heart diseases have led to an increase in patients’ age and frequency of comorbidities [2, 3].”
BackgroundSelf-citationMurdoch, D. R. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.603 · Cited by 2,362 · cited 3×
“pathogens in cases of IE [9]; these findings were later confirmed by different observational studies [1, 6].”
BackgroundResultSelf-citationFriedman, N. D., Kaye, K. S., Stout, J. E., McGarry, S. A., Trivette, S. L., Briggs, J. P., Lamm, W., Clark, C., MacFarquhar, J., Walton, A. L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-10-200211190-00007 · Cited by 1,668 · cited 1×
“The mode of IE acquisition was categorized on the basis of 3 mutually exclusive classes: (1) injection drug use–associated IE, (2) community-acquired IE, and (3) healthcare-associated IE, which included nosocomial and nonnosocomial IE, according to prior definitions [6, 14–16] described in detail in the supplementary…”
MethodStaphylococcus aureus Endocarditis: A Consequence of Medical Progress
Fowler, V. G., Miro, J. M., Hoen, B., Cabell, C. H., Abrutyn, E., Rubinstein, E., Corey, G. R., Spelman, D., Bradley, S. F., Barsic, B., et al. (2005) · JAMA · doi:10.1001/jama.293.24.3012 · Cited by 1,174 · cited 6×
“aureus IE study by Fowler et al [6].”
BackgroundMethodResultInfluentialSelf-citationJarraud, S., Mougel, C., Thioulouse, J., Lina, G., Meugnier, H., Forey, F., Nesme, X., Etienne, J., & Vandenesch, F. (2002) · Infection and Immunity · doi:10.1128/iai.70.2.631-641.2002 · Cited by 1,151 · cited 1×
“Microbiologists were asked to send all strains of streptococci and staphylococci to the corresponding national reference centers, where identification was confirmed on the basis of phenotypic and molecular microbiology techniques [17–19].”
BackgroundSelf-citationChanging Profile of Infective Endocarditis<SUBTITLE>Results of a 1-Year Survey in France</SUBTITLE>
Hoen, B. (2002) · JAMA · doi:10.1001/jama.288.1.75 · Cited by 987
Self-citationMoreillon, P., & Que, Y.-A. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15266-x · Cited by 861
Research works printed but not linked: 1
- 2002, Changing profile of infective endocarditis: results of a one-year survey in France in 1999, JAMA, 288, 75
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
Self-citationBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
2023 ESC Guidelines for the management of endocarditis
Delgado, V., Ajmone Marsan, N., de Waha, S., Bonaros, N., Brida, M., Burri, H., Caselli, S., Doenst, T., Ederhy, S., Erba, P. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad193 · Cited by 1,754
Self-citationCoagulase-Negative Staphylococci
Becker, K., Heilmann, C., & Peters, G. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00109-13 · Cited by 1,628
Cahill, T. J., & Prendergast, B. D. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00067-7 · Cited by 991
Habib, G., Erba, P. A., Iung, B., Donal, E., Cosyns, B., Laroche, C., Popescu, B. A., Prendergast, B., Tornos, P., Sadeghpour, A., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz620 · Cited by 911
Self-citationChallenges in Infective Endocarditis
Cahill, T. J., Baddour, L. M., Habib, G., Hoen, B., Salaun, E., Pettersson, G. B., Schäfers, H. J., & Prendergast, B. D. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.066 · Cited by 715
“Concurrently, staphylococci overtook oral streptococci as the most frequent causative organism (9,10).”
BackgroundInfluentialSelf-citationHoen, B., & Duval, X. (2013) · New England Journal of Medicine · doi:10.1056/nejmcp1206782 · Cited by 467
Self-citationEpidemiology of Acquired Valvular Heart Disease
Iung, B., & Vahanian, A. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.03.022 · Cited by 388
Self-citationManagement Considerations in Infective Endocarditis: A Review
Wang, A., Gaca, J. G., & Chu, V. H. (2018) · JAMA · doi:10.1001/jama.2018.7596 · Cited by 368
Infective endocarditis: A contemporary update
Rajani, R., & Klein, J. L. (2020) · Clinical Medicine · doi:10.7861/clinmed.cme.20.1.1 · Cited by 332
Fernández-Hidalgo, N., Almirante, B., Gavaldà, J., Gurgui, M., Peña, C., de Alarcón, A., Ruiz, J., Vilacosta, I., Montejo, M., Vallejo, N., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit052 · Cited by 311
Chu, V. H., Park, L. P., Athan, E., Delahaye, F., Freiberger, T., Lamas, C., Miro, J. M., Mudrick, D. W., Strahilevitz, J., Tribouilloy, C., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.012461 · Cited by 280
Self-citationHACEK Infective Endocarditis: Characteristics and Outcomes from a Large, Multi-National Cohort
Chambers, S. T., Murdoch, D., Morris, A., Holland, D., Pappas, P., Almela, M., Fernández-Hidalgo, N., Almirante, B., Bouza, E., Forno, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063181 · Cited by 237
Bin Abdulhak, A. A., Baddour, L. M., Erwin, P. J., Hoen, B., Chu, V. H., Mensah, G. A., & Tleyjeh, I. M. (2014) · Global Heart · doi:10.1016/j.gheart.2014.01.002 · Cited by 233
Self-citationThe Changing Epidemiology of Infective Endocarditis in the Twenty-First Century
the Hospital Clinic Infective Endocarditis Investigators, Ambrosioni, J., Hernandez-Meneses, M., Téllez, A., Pericàs, J., Falces, C., Tolosana, J., Vidal, B., Almela, M., Quintana, E., et al. (2017) · Current Infectious Disease Reports · doi:10.1007/s11908-017-0574-9 · Cited by 212
Chen, H., Zhan, Y., Zhang, K., Gao, Y., Chen, L., Zhan, J., Chen, Z., & Zeng, Z. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.774224 · Cited by 194
Quantifying infective endocarditis risk in patients with predisposing cardiac conditions
Thornhill, M. H., Jones, S., Prendergast, B., Baddour, L. M., Chambers, J. B., Lockhart, P. B., & Dayer, M. J. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx655 · Cited by 194
Kuijpers, J. M., Koolbergen, D. R., Groenink, M., Peels, K. H., Reichert, C. L. A., Post, M. C., Bosker, H. A., Wajon, E. M. C. J., Zwinderman, A. H., Mulder, B. J. M., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehw591 · Cited by 187
“As generally found for ACHD-related IE, median age of occurrence ( 38 years) was low compared with general IE (60–70 years).(8,18,19) Prosthetic material did not presently influence outcome.”
BackgroundResultPrediction of Symptomatic Embolism in Infective Endocarditis
Hubert, S., Thuny, F., Resseguier, N., Giorgi, R., Tribouilloy, C., Le Dolley, Y., Casalta, J.-P., Riberi, A., Chevalier, F., Rusinaru, D., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.029 · Cited by 185
“However, these recommendations are based on a low level of evidence, and the rate of embolic events remains high despite their routine use (10,15).”
BackgroundAntibiotic prophylaxis for infective endocarditis: a systematic review and meta-analysis
Cahill, T. J., Harrison, J. L., Jewell, P., Onakpoya, I., Chambers, J. B., Dayer, M., Lockhart, P., Roberts, N., Shanson, D., Thornhill, M., et al. (2017) · Heart · doi:10.1136/heartjnl-2015-309102 · Cited by 181
JCS 2017 Guideline on Prevention and Treatment of Infective Endocarditis
Nakatani, S., Ohara, T., Ashihara, K., Izumi, C., Iwanaga, S., Eishi, K., Okita, Y., Daimon, M., Kimura, T., Toyoda, K., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0549 · Cited by 179
Chirouze, C., Athan, E., Alla, F., Chu, V. H., Ralph Corey, G., Selton-Suty, C., Erpelding, M.-L., Miro, J. M., Olaison, L., & Hoen, B. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12166 · Cited by 176
“of IE collected, enterococcal IE was the third most frequent group of IE, occurred more frequently in patients with prosthetic valves, and was more prone to be nosocomially acquired than oral or group D streptococcal IE [15].”
BackgroundSelf-citationIncidence, Microbiology, and Outcomes in Patients Hospitalized With Infective Endocarditis
Shah, A. S. V., McAllister, D. A., Gallacher, P., Astengo, F., Rodríguez Pérez, J. A., Hall, J., Ken Lee, K., Bing, R., Anand, A., Nathwani, D., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044913 · Cited by 173
Brain MRI Findings in Neurologically Asymptomatic Patients with Infective Endocarditis
Hess, A., Klein, I. F., Iung, B., Lavallée, P. C., Ilic-Habensus, E., Dornic, Q., Arnoult, F., Mimoun, L., Wolff, M., Duval, X., et al. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3582 · Cited by 169
Self-citation2015 ESC Guidelines for the management of infective endocarditis
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · Kardiologia Polska · doi:10.5603/kp.2015.0227 · Cited by 165
Self-citationStaphylococcus aureusbacteraemia and endocarditis – epidemiology and outcome: a review
Ásgeirsson, H., Thalme, A., & Weiland, O. (2017) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2017.1392039 · Cited by 163
“90/100,000 adults [6], in an Italian region during 2000–05 it was 0.”
BackgroundUpdate on blood culture-negative endocarditis
Tattevin, P., Watt, G., Revest, M., Arvieux, C., & Fournier, P. (2014) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2014.11.003 · Cited by 163
“Histoplasma capsulatum, Streptococcus viridans, Propionibacterium acnes, and Cardiobacterium hominis (JM Miller, ClinMicroNet 1999, unpublished data); the main pathogens causing endocarditis in France are: staphylococci (35% of cases), streptococci (35%), and enterococci (10%) [2,5].”
BackgroundSelf-citationCoagulation: At the heart of infective endocarditis
Liesenborghs, L., Meyers, S., Vanassche, T., & Verhamme, P. B. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14736 · Cited by 159
Endocarditis and Intravascular Infections
Fowler, V. G., Scheld, W. M., & Bayer, A. S. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00082-5 · Cited by 152
Association between Endodontic Infection, Its Treatment and Systemic Health: A Narrative Review
Niazi, S. A., & Bakhsh, A. (2022) · Medicina · doi:10.3390/medicina58070931 · Cited by 150
HACEK endocarditis: state-of-the-art
Revest, M., Egmann, G., Cattoir, V., & Tattevin, P. (2016) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2016.1164032 · Cited by 140
“The HACEK group is responsible for 1.2-3% of all IE cases [1 2 6-9].”
InfluentialSelf-citationAlagna, L., Park, L. P., Nicholson, B. P., Keiger, A., Strahilevitz, J., Morris, A., WRAY, D. W., Gordon, D., Delahaye, F., Edathodu, J., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12395 · Cited by 129
“Factors such as IDU, increase in implantable devices, and invasive procedures have contributed to this [12,13,16,25].”
BackgroundSelf-citationStaphylococcus aureus Bloodstream Infection and Endocarditis - A Prospective Cohort Study
Moing, V. L., Alla, F., Doco‐Lecompte, T., Delahaye, F., Piroth, L., Chirouze, C., Tattevin, P., Lavigne, J., Erpelding, M., Hoen, B., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127385 · Cited by 128
“Furthermore, S . aureus has become, during the last decade, the leading cause of IE in Western Europe and North America [13 – 15], and a microorganism clearly identified in IE patients, as responsible for the highest rates of morbidity and mortality [14 – 16].”
Self-citationTernhag, A., Cederström, A., Törner, A., & Westling, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067519 · Cited by 128
“A lower incidence of IE has been reported in repeated population-based prospective studies from France [10], the latest performed in 2008 [11] including 497 patients, with an incidence of 3.”
BackgroundResultSystematic Search for Present and Potential Portals of Entry for Infective Endocarditis
Delahaye, F., M’Hammedi, A., Guerpillon, B., de Gévigney, G., Boibieux, A., Dauwalder, O., Bouchiat, C., & Vandenesch, F. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.065 · Cited by 123
Self-citationFernández‐Hidalgo, N., Almirante, B., Tornos, P., González-Alujas, M. T., Planes, A. M., Galiñanes, M., & Pahissa, A. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12033 · Cited by 120
“undergone many epidemiological changes, as has been widely described [2,22,23], and our results corroborate this.”
BackgroundResultIung, B., Doco‐Lecompte, T., Chocron, S., Strady, C., Delahaye, F., Moing, V. L., Poyart, C., Alla, F., Cambau, E., Tattevin, P., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv650 · Cited by 120
“Survey organization, data collection, and variables analysed were previously detailed.(12) All cases were validated according to the case report forms by an expert team in each administrative area.”
MethodSelf-citationLamas, C. D. C., Fournier, P., Zappa, M., Brandão, T. J. D., Januário-da-Silva, C. A., Correia, M. G., Barbosa, G. I. F., Golebiovski, W. F., Weksler, C., Lépidi, H., et al. (2015) · Infection · doi:10.1007/s15010-015-0863-x · Cited by 111
“In Europe, the incidence of BCNE has been reported to be 13 % in the UK [2], 14 % in Spain [3], 9 % in France [4], 24 % in Sweden [5] and 25 % in Italy [6].”
BackgroundInfluentialDahl, A., Rasmussen, R. V., Bundgaard, H., Hassager, C., Bruun, L. E., Lauridsen, T. K., Moser, C., Sogaard, P., Arpi, M., & Bruun, N. E. (2013) · Circulation · doi:10.1161/circulationaha.112.001170 · Cited by 108
Fungal endocarditis: current challenges
Tattevin, P., Revest, M., Lefort, A., Michelet, C., & Lortholary, O. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.07.003 · Cited by 108
Self-citationYang, X., Chen, H., Zhang, D., Shen, L., An, G., & Zhao, S. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab184 · Cited by 106
Long-term outcomes and cardiac surgery in critically ill patients with infective endocarditis
Mirabel, M., Sonneville, R., Hajage, D., Novy, E., Tubach, F., Vignon, P., Perez, P., Lavoué, S., Kouatchet, A., Pajot, O., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht303 · Cited by 106
Chirouze, C., Alla, F., Fowler, V. G., Sexton, D. J., Corey, G. R., Chu, V. H., Wang, A., Erpelding, M.-L., Durante-Mangoni, E., Fernández-Hidalgo, N., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu871 · Cited by 104
Self-citationGalar, A., Weil, A. A., Dudzinski, D. M., Muñóz, P., & Siedner, M. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00041-18 · Cited by 103
Infective Endocarditis: Prevention, Diagnosis, and Management
Thuny, F., Grisoli, D., Cautela, J., Ribéri, A., Raoult, D., & Habib, G. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.03.042 · Cited by 103
Prognostic Value of Skin Manifestations of Infective Endocarditis
Servy, A., Valeyrie‐Allanore, L., Alla, F., Lechiche, C., Nazeyrollas, P., Chidiac, C., Hoen, B., Chosidow, O., & Duval, X. (2014) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.8727 · Cited by 101
Self-citationØstergaard, L., Bruun, N. E., Voldstedlund, M., Arpi, M., Andersen, C. Ø., Schønheyder, H. C., Lemming, L. E., Rosenvinge, F. S., Valeur, N., Søgaard, P., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz327 · Cited by 101
Iung, B., Tubiana, S., Klein, I. F., Messika–Zeitoun, D., Brochet, É., Lepage, L., Al‐Attar, N., Ruimy, R., Leport, C., Wolff, M., et al. (2013) · Stroke · doi:10.1161/strokeaha.113.001470 · Cited by 98
Self-citationInfective endocarditis: innovations in the management of an old disease
Iung, B., & Duval, X. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0215-0 · Cited by 95
Self-citationKong, W. K. F., Salsano, A., Giacobbe, D. R., Popescu, B. A., Laroche, C., Duval, X., Schueler, R., Moreo, A. M., Colonna, P., Piper, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac307 · Cited by 94
Self-citationEpidemiología de la endocarditis infecciosa en España en los últimos 20 años
Fernández‐Hidalgo, N., & Tornos, P. (2013) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.05.003 · Cited by 94
Temporal trends in infective endocarditis epidemiology from 2007 to 2013 in Olmsted County, MN
DeSimone, D. C., Tleyjeh, I. M., Correa de Sa, D. D., Anavekar, N. S., Lahr, B. D., Sohail, M. R., Steckelberg, J. M., Wilson, W. R., & Baddour, L. M. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.07.007 · Cited by 93
Østergaard, L., Valeur, N., Ihlemann, N., Smerup, M., Bundgaard, H., Gislason, G., Torp-Pedersen, C. T., Bruun, N. E., Køber, L., & Fosbøl, E. L. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy153 · Cited by 93
Simple Scoring System to Predict In‐Hospital Mortality After Surgery for Infective Endocarditis
Gatti, G., Perrotti, A., Obadia, J., Duval, X., Iung, B., Alla, F., Chirouze, C., Selton‐Suty, C., Hoen, B., Sinagra, G., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004806 · Cited by 91
Self-citationAmbrosioni, J., Meneses, M. H., Durante‐Mangoni, E., Tattevin, P., Olaison, L., Freiberger, T., Hurley, J. P., Hannan, M. M., Chu, V. H. Y., Hoen, B., et al. (2023) · Infectious Diseases and Therapy · doi:10.1007/s40121-023-00763-8 · Cited by 91
Self-citationInvasive streptococcal disease: a review for clinicians
Parks, T., Barrett, L. K., & Jones, N. (2015) · British Medical Bulletin · doi:10.1093/bmb/ldv027 · Cited by 91
Infective Endocarditis: A Focus on Oral Microbiota
Giudice, C. D., Vaia, E., Liccardo, D., Marzano, F., Valletta, A., Spagnuolo, G., Ferrara, N., Rengo, C., Cannavò, A., & Rengo, G. (2021) · Microorganisms · doi:10.3390/microorganisms9061218 · Cited by 90
Siméon, S., Moing, V. L., Tubiana, S., Duval, X., Fournier, P., Lavigne, J., Erpelding, M., Gustave, C.-A., Desage, S., Chirouze, C., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.07.015 · Cited by 90
“prevalent microorganism causing infective endocardi tis (IE) (8,9), a major complication of 61 SAB (10,11).”
BackgroundSelf-citationMackie, A. S., Liu, W., Savu, A., Marelli, A. J., & Kaul, P. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.09.021 · Cited by 90
“%) and Selton-Suty et al.33 (27”
BackgroundAhtela, E., Oksi, J., Porela, P., Ekström, T., Rautava, P. T., & Kytö, V. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-026811 · Cited by 88
“term mortality of IE has been reported to be 10%–24%.(3) 5 7 18 Despite the development of”
BackgroundPappelbaum, K. I., Gorzelanny, C., Grässle, S., Suckau, J., Laschke, M. W., Bischoff, M., Bauer, C., Schorpp-Kistner, M., Weidenmaier, C., Schneppenheim, R., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002008 · Cited by 84
Infective endocarditis and oral health—a Narrative Review
Bumm, C. V., & Folwaczny, M. (2021) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-908 · Cited by 83
“(9), Staphylococcus aureus is considered the most common in high-income countries (10).”
BackgroundCahill, T., Jewell, P., Denne, L., Franklin, R., Frigiola, A., Orchard, E., & Prendergast, B. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.05.014 · Cited by 83
Mzabi, A., Kernéis, S., Richaud, C., Podglajen, I., Fernandez‐Gerlinger, M., & Mainardi, J. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.04.003 · Cited by 83
“The distribution of the bacterial species has also evolved substantially, with an increase in Streptococcus bovis/Streptococcus gallolyticus and Staphylococcus aureus [2,4,5].”
BackgroundEnterococcus faecalisinfective endocarditis: focus on clinical aspects
Dahl, A., & Bruun, N. E. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.832482 · Cited by 80
Epidemiology of Infective Endocarditis in Spain in the Last 20 Years
Fernández‐Hidalgo, N., & Tornos, P. (2013) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.05.002 · Cited by 79
“4 episodes per 100 000 inhabitants/year).(7)”
Role of age and comorbidities in mortality of patients with infective endocarditis
Armiñanzas, C., Fariñas-Álvarez, C., Zarauza, J., Muñóz, P., Ramallo, V. J. G., Selles, M. M., Meda, J. M. M., Pericàs, J. M., Goenaga, M. Á., Burgos, G. O., et al. (2019) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.03.006 · Cited by 78
Williams, M. L., Doyle, M., McNamara, N., Tardo, D. T., Mathew, M., & Robinson, B. M. (2021) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/17539447211002687 · Cited by 77
Duval, X., Millot, S., Chirouze, C., Selton‐Suty, C., Moby, V., Tattevin, P., Strady, C., Euvrard, E., Agrinier, N., Thomas, D., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix237 · Cited by 76
“Trained clinical research assistants prospectively collected clinical, biological and therapeutic IE data using a standardized case report form as previously described [21].”
MethodSelf-citationMechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection
Yeaman, M. R., Filler, S. G., Chaili, S., Barr, K., Wang, H., Kupferwasser, D., Hennessey, J. P., Fu, Y., Schmidt, C. S., Edwards, J. E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415610111 · Cited by 76
Aminoglycosides for infective endocarditis: time to say goodbye?
Lebeaux, D., Fernández‐Hidalgo, N., Pilmis, B., Tattevin, P., & Mainardi, J. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.10.017 · Cited by 74
Managing infective endocarditis in the elderly: new issues for an old disease
Forestier, E., Fraisse, T., Baudron, C. R., Selton‐Suty, C., & Pagani, L. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s101902 · Cited by 73
Self-citationTemporal changes in the incidence of infective endocarditis in Denmark 1997–2017: A nationwide study
Jensen, A. D., Bundgaard, H., Butt, J. H., Bruun, N. E., Voldstedlund, M., Torp-Pedersen, C. T., Gislason, G., Iversen, K. K., Chamat‐Hedemand, S., Dahl, A., et al. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.10.029 · Cited by 73
Infective Endocarditis in High-Income Countries
Nappi, F., Martuscelli, G., Bellomo, F., Singh, S. S. A., & Moon, M. R. (2022) · Metabolites · doi:10.3390/metabo12080682 · Cited by 71
“At the same time, Staphylococcus strains became the most widely found causative pathogen, replacing oral streptococci [1,2,4,5].”
BackgroundInfectious endocarditis and infection of intracardiac devices in adults. Clinical guidelines 2021
Демин, А. А., Kobalava, Z. D., Skopin, I. I., Tyurin, P. V., Boytsov, S. A., Golukhova, E. Z., Гордеев, М. Л., Gudymovich, V. D., Demchenko, E. A., Дробышева, В. П., et al. (2022) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2022-5233 · Cited by 69
Selton‐Suty, C., Delahaye, F., Tattevin, P., Federspiel, C., Moing, V. L., Chirouze, C., Nazeyrollas, P., Vernet-Garnier, V., Bernard, Y. F., Chocron, S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158522 · Cited by 67
“[7] The design of this study and the type of data recorded have been described in details previously.[8] The study was approved by an institutional review committee (Comité de Protection des Personnes, Besançon, December 2007).”
MethodSelf-citationEuroSCORE II underestimates mortality after cardiac surgery for infective endocarditis
Patrat-Delon, S., Rouxel, A., Gacouin, A., Revest, M., Flecher, E. M., Fouquet, O., Tulzo, Y. L., Lerolle, N., Tattevin, P., & Tadié, J. (2015) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezv223 · Cited by 66
Self-citationDistribution of streptococcal groups causing infective endocarditis: a descriptive study
Kim, S. L., Gordon, S. M., & Shrestha, N. K. M. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.02.015 · Cited by 66
Dental Management Considerations for Patients with Cardiovascular Disease—A Narrative Review
Gupta, K., Kumar, S., Kukkamalla, M. A., Taneja, V., Syed, G. A., Pullishery, F., Zarbah, M., Alqahtani, S. M., Alobaoid, M. A., & Chaturvedi, S. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2308261 · Cited by 65
“In-hospital mortality of this disease is 15–22% [77,78] and the 5-year mortality rate is around 40% [79].”
BackgroundCecchi, E., Chirillo, F., Castiglione, A., Faggiano, P. M., Cecconi, M., Moreo, A. M., Cialfi, A., Rinaldi, M., del Ponte, S., Squeri, A., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.04.123 · Cited by 64
N’Guyen, Y., Duval, X., Revest, M., Saada, M., Erpelding, M., Selton‐Suty, C., Bouchiat, C., Delahaye, F., Chirouze, C., Alla, F., et al. (2016) · Annals of Medicine · doi:10.1080/07853890.2016.1235282 · Cited by 64
“For this study, we analyzed the database that had been created for the purpose of the French population-based epidemiological survey on definite IE in 2008, which methods and results have been published elsewhere (8).”
MethodSelf-citationCurlier, E., Hoen, B., Alla, F., Selton‐Suty, C., Schubel, L., Doco‐Lecompte, T., Minary, L., Erpelding, M., Duval, X., & Chirouze, C. (2014) · Heart · doi:10.1136/heartjnl-2013-304916 · Cited by 64
Self-citationAccuracy of administrative data for identification of patients with infective endocarditis
Tan, C., Hansen, M., Cohen, G. N., Boyle, K., Daneman, N., & Adhikari, N. K. J. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.09.030 · Cited by 63
Imaging investigations in infective endocarditis: Current approach and perspectives
Thuny, F., Gaubert, J., Jacquier, A., Tessonnier, L., Cammilleri, S., Raoult, D., & Habib, G. (2012) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2012.09.004 · Cited by 62
“Infective endocarditis (IE) is a serious disease associated with poor prognosis despite improvements in medical and surgical therapies [1—4].”
BackgroundInfective endocarditis requiring ICU admission: epidemiology and prognosis
Leroy, O., Georges, H., Devos, P., Bitton, S., de, N., Dedrie, C., Beague, S., Ducq, P., Geronimi, C. B., Thellier, D., et al. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0091-7 · Cited by 62
“aureus IE [14].”
Millot, S., Lesclous, P., Colombier, M., Radoï, L., Messeca, C., Ballanger, M., Charrier, J.-L., Tramba, P., Simon, S., Berrebi, A., et al. (2017) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2017.01.012 · Cited by 61
“[8] Selton-Suty C, Celard M, Le Moing V, et al.”
BackgroundSelf-citationIncidence, characteristics, and mortality of infective endocarditis in France in 2011
Sunder, S., Grammatico‐Guillon, L., Lemaignen, A., Lacasse, M., Gaborit, C., Boutoille, D., Tattevin, P., Denes, É., Guimard, T., Dupont, M., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223857 · Cited by 61
“Some results differed substantially from the previous multicenter French population-based study [2], with a higher incidence of IE in the regional study estimation, a recourse of valvular surgery considerably less frequent, whereas mortality was similar.”
BackgroundResultSurgical results for prosthetic versus native valve endocarditis: A multicenter analysis
Weber, C., Petrov, G., Luehr, M., Aubin, H., Tugtekin, S., Borger, M. A., Akhyari, P., Wahlers, T., Hagl, C. M., Matschke, K. E., et al. (2019) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.09.186 · Cited by 60
Chan, L. C., Chaili, S., Filler, S. G., Barr, K., Wang, H., Kupferwasser, D., Edwards, J. E., Xiong, Y. Q., Ibrahim, A. S., Miller, L. S., et al. (2015) · Infection and Immunity · doi:10.1128/iai.01061-15 · Cited by 59
“The public health impact of this trend is of urgent concern, especially 63 given a 15-40% mortality rate associated with invasive MRSA infection (22, 23).”
BackgroundYavuz, S. Ş., Şensoy, A., Kaşıkçıoğlu, H., Çeken, S., Deniz, D., Yavuz, A., Koçak, F., Midilli, K., Eren, M., & Yekeler, İ. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.11.007 · Cited by 59
Surgery for Infective Endocarditis: Outcomes and Predictors of Mortality in 360 Consecutive Patients
Farag, M. B., Borst, T., Sabashnikov, A., Zeriouh, M., Schmack, B., Arif, R., Beller, C. J., Popov, A., Kallenbach, K., Ruhparwar, A., et al. (2017) · Medical Science Monitor · doi:10.12659/msm.902340 · Cited by 58
“aureus has replaced Streptococci as the most common pathogen in IE [24,25].”
BackgroundLoubet, P., Lescure, F.-X., Lepage, L., Kirsch, M. E. W., Armand-Lefèvre, L., Bouadma, L., Lariven, S., Duval, X., Yazdanpanah, Y., & Joly, V. (2015) · Scandinavian Journal of Infectious Diseases · doi:10.3109/23744235.2015.1075660 · Cited by 58
Self-citationBouchiat, C., Moreau, K., Devillard, S., Rasigade, J., Mosnier, A., Geissmann, T., Bes, M., Tristan, A., Lina, G., Laurent, F. J., et al. (2015) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2015.08.029 · Cited by 58
Self-citationHigh-dose trimethoprim-sulfamethoxazole and clindamycin for Staphylococcus aureus endocarditis
Tissot‐Dupont, H., Gouriet, F., Oliver, L., Jamme, M., Casalta, J., Jimeno, M.-T., Arregle, F., Lavoûte, C., Hubert, S., Philip, M., et al. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.06.006 · Cited by 57
Endocardite infectieuse. Épidémiologie, physiopathologie et anatomopathologie
Iung, B. (2019) · La Presse Médicale · doi:10.1016/j.lpm.2019.04.009 · Cited by 57
Self-citationNeurological complications of infective endocarditis: New breakthroughs in diagnosis and management
Novy, E., Sonneville, R., Mazighi, M., Klein, I. F., Mariotte, É., Mourvillier, B., Bouadma, L., & Wolff, M. (2013) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2013.09.010 · Cited by 56
Cimmino, G., Bottino, R., Formisano, T., Orlandi, M., Molinari, D., Sperlongano, S., Castaldo, P., D’Elia, S., Carbone, A., Palladino, A., et al. (2023) · Life · doi:10.3390/life13020377 · Cited by 55
“The in-hospital mortality rate is high, ranging from 14 to 22% [9,10], with a high incidence of per year mortality (up to 15–30%) [4] and a five-year survival rate, similar or even worse, than some cancers [4,11].”
BackgroundO’Carroll, C. B., & Barrett, K. M. (2017) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000419 · Cited by 55
“Multiple microorganisms can cause infective endocarditis, but the most common are Staphylococcus aureus, Streptococcus viridans, and Enterococcus.(50) All patients with suspected infective endocarditis should have at least two sets of blood cultures, complete blood cell count, TTE, serial ECGs, and TEE.”
Background
Metadata
- Authors
- Selton-Suty, C., Célard, M., Le Moing, V., Doco-Lecompte, T., Chirouze, C., Iung, B., Strady, C., Revest, M., Vandenesch, F., Bouvet, A., Delahaye, F., Alla, F., Duval, X., & Hoen, B.
- Affiliations
- Laboratoire Chrono-Environnement (FR)
- Hôpital Pontchaillou (FR)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- Hôpital Bichat-Claude-Bernard (FR)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-05-01
- Volume
- 54
- Issue
- 9
- Pages
- 1230-1239
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2155794989
- Semantic Scholar
- 46e2ed77823a43f31fbb6342dfb12aabb30be85d
- Cited by
- 710
- References
- 29
- Citations by year
- 2026: 30 · 2025: 37 · 2024: 55 · 2023: 66 · 2022: 64 · 2021: 51 · 2020: 65 · 2019: 67 · 2018: 42 · 2017: 53 · 2016: 56 · 2015: 47 · 2014: 32 · 2013: 35 · 2012: 8
- FWCI
- 29.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- infective endocarditis, Staphylococcus aureus, coagulase-negative staphylococci, community-acquired endocarditis, incidence, in-hospital mortality, risk factors, referral bias
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Cross Infection, Endocarditis, Bacterial, Female, France, Hospitals, Humans, Male, Middle Aged, Population Surveillance, Prognosis, Risk Factors, Staphylococcal Infections, Staphylococcus, Staphylococcus aureus, Incidence, Community-Acquired Infections, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.